Kaplan–Meier analysis revealed that the RFS in patients with ERα-positive breast cancer treated with endocrine therapy is significantly decreased in 167 patients with high NgBR expression in tumors as compared to 168 patients with low NgBR expression in tumors (p < 0.05). Here, ESR1 is linked to breast carcinoma.